FindTrial
Sign In

Plant Extracts

7 trials

Sponsors

Centre of Natural Products/National Centre for Scientifc Research, Aboca SpA Società Agricola laboratories, Center for Technological Applications and Nuclear Development (CEADEN), National Centre for Scientific Research

Conditions

Benign Prostatic Hyperplasia BPHBenign Prostatic Hyperplasia Lower urinary tract symptomsCOVID-19 COVID-19 SARS-CoV2COVID-19 COVID-19 SARS-CoV2Irritable bowel syndrome

Phase 3

D004 vs terazosin
Active, not recruitingRPCEC00000217
Centre of Natural Products/National Centre for Scientifc ResearchBenign Prostatic Hyperplasia Lower urinary tract symptoms
Start: 2017-01-15Target: 100Updated: 2026-03-30
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III
Active, not recruitingRPCEC00000294
Aboca SpA Società Agricola laboratoriesIrritable bowel syndrome
Start: 2018-12-10Target: 140Updated: 2026-03-30
D004 (Palmex) vs Saw palmetto, Finasteride and Tamsulosin in patients with BPH
Active, not recruitingRPCEC00000373
National Centre for Scientific ResearchBenign Prostatic Hyperplasia BPH
Start: 2021-09-01Target: 200Updated: 2026-03-30

Unknown Phase

Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia
Active, not recruitingRPCEC00000344
Center for Technological Applications and Nuclear Development (CEADEN)COVID-19 COVID-19 SARS-CoV2
Start: 2020-03-19Target: 199Updated: 2026-03-30
Curmeric- Safety-Community-Quarantine-COVID-19
Active, not recruitingRPCEC00000350
Center for Technological Applications and Nuclear Development (CEADEN)COVID-19 COVID-19 SARS-CoV2
Start: 2020-09-21Target: 186Updated: 2026-03-30
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19
Active, not recruitingRPCEC00000351
Center for Technological Applications and Nuclear Development (CEADEN)COVID-19 COVID-19 SARS-CoV2
Start: 2020-10-03Target: 340Updated: 2026-03-30
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19
Active, not recruitingRPCEC00000352
Center for Technological Applications and Nuclear Development (CEADEN)COVID-19 COVID-19 SARS-CoV2
Start: 2020-10-21Target: 148Updated: 2026-03-30